HK1199449A1 - Processes and intermediates for preparing a macrocyclic protease inhibitor of hcv hcv - Google Patents

Processes and intermediates for preparing a macrocyclic protease inhibitor of hcv hcv

Info

Publication number
HK1199449A1
HK1199449A1 HK14113084.4A HK14113084A HK1199449A1 HK 1199449 A1 HK1199449 A1 HK 1199449A1 HK 14113084 A HK14113084 A HK 14113084A HK 1199449 A1 HK1199449 A1 HK 1199449A1
Authority
HK
Hong Kong
Prior art keywords
hcv
intermediates
preparing
processes
protease inhibitor
Prior art date
Application number
HK14113084.4A
Other languages
English (en)
Chinese (zh)
Inventor
Dominique Paul Michel Depr
Dominic John Ormerod
Andras Horvath
Original Assignee
Janssen Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceuticals Inc filed Critical Janssen Pharmaceuticals Inc
Publication of HK1199449A1 publication Critical patent/HK1199449A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/16—Preparation of optical isomers
    • C07C231/18—Preparation of optical isomers by stereospecific synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/40—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/82—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/84—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • C07D453/04—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems having a quinolyl-4, a substituted quinolyl-4 or a alkylenedioxy-quinolyl-4 radical linked through only one carbon atom, attached in position 2, e.g. quinine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK14113084.4A 2011-09-22 2014-12-31 Processes and intermediates for preparing a macrocyclic protease inhibitor of hcv hcv HK1199449A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11182375 2011-09-22
PCT/EP2012/068593 WO2013041655A1 (en) 2011-09-22 2012-09-21 Processes and intermediates for preparing a macrocyclic protease inhibitor of hcv

Publications (1)

Publication Number Publication Date
HK1199449A1 true HK1199449A1 (en) 2015-07-03

Family

ID=46924427

Family Applications (1)

Application Number Title Priority Date Filing Date
HK14113084.4A HK1199449A1 (en) 2011-09-22 2014-12-31 Processes and intermediates for preparing a macrocyclic protease inhibitor of hcv hcv

Country Status (16)

Country Link
US (1) US9227965B2 (xx)
EP (1) EP2758386A1 (xx)
JP (1) JP6235473B2 (xx)
KR (1) KR20140063726A (xx)
CN (2) CN103906739B (xx)
AR (1) AR087993A1 (xx)
AU (1) AU2012311461B2 (xx)
BR (1) BR112014006984A2 (xx)
CA (1) CA2845720A1 (xx)
CL (1) CL2014000687A1 (xx)
EA (1) EA201490675A1 (xx)
HK (1) HK1199449A1 (xx)
IL (1) IL231024A (xx)
MX (1) MX356686B (xx)
TW (1) TWI565704B (xx)
WO (1) WO2013041655A1 (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA41812A (fr) 2015-03-27 2018-01-30 Janssen Pharmaceuticals Inc Procédés et intermédiaires pour la préparation d'un inhibiteur de protéase macrocyclique du vhc

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1713822B1 (en) 2004-01-30 2010-03-17 Medivir AB Hcv ns-3 serine protease inhibitors
PE20070211A1 (es) 2005-07-29 2007-05-12 Medivir Ab Compuestos macrociclicos como inhibidores del virus de hepatitis c
EP2121674B1 (en) * 2007-02-01 2010-05-12 Tibotec Pharmaceuticals Processes and intermediates for preparing a macrocyclic protease inhibitor of hcv
US8426360B2 (en) * 2007-11-13 2013-04-23 Enanta Pharmaceuticals, Inc. Carbocyclic oxime hepatitis C virus serine protease inhibitors
EP2382198B1 (en) * 2008-12-23 2013-07-10 Janssen Pharmaceuticals, Inc. Processes and intermediates for preparing a macrocyclic protease inhibitor of hcv
EA201290128A1 (ru) * 2009-09-28 2013-01-30 Интермьюн, Инк. Новые макроциклические ингибиторы репликации вируса гепатита с
EP3239129A1 (en) * 2010-03-16 2017-11-01 Janssen Pharmaceuticals, Inc. Processes and intermediates for preparing a macrocyclic protease inhibitor of hcv

Also Published As

Publication number Publication date
CA2845720A1 (en) 2013-03-28
IL231024A (en) 2017-09-28
MX356686B (es) 2018-06-07
AU2012311461A1 (en) 2014-03-06
EA201490675A1 (ru) 2014-08-29
AR087993A1 (es) 2014-04-30
MX2014003509A (es) 2014-07-22
EP2758386A1 (en) 2014-07-30
JP6235473B2 (ja) 2017-11-22
KR20140063726A (ko) 2014-05-27
CN103906739B (zh) 2016-12-28
US20140228574A1 (en) 2014-08-14
IL231024A0 (en) 2014-03-31
CN103906739A (zh) 2014-07-02
BR112014006984A2 (pt) 2017-04-04
TWI565704B (zh) 2017-01-11
CN107011339A (zh) 2017-08-04
TW201329074A (zh) 2013-07-16
AU2012311461B2 (en) 2017-07-06
CL2014000687A1 (es) 2014-08-01
US9227965B2 (en) 2016-01-05
JP2014528943A (ja) 2014-10-30
WO2013041655A1 (en) 2013-03-28

Similar Documents

Publication Publication Date Title
HK1199445A1 (zh) 用於製備 抑制劑的方法和中間體
EP2744507A4 (en) CRYSTAL FORMS OF AN HCV PROTEASE HEMMER
HUS1700039I1 (hu) Makrociklusos prolinból leszármaztatható HCV szerin proteáz inhibitorok
HK1217952A1 (zh) 用於製備 的大環蛋白酶抑制劑的方法和中間體
EP2780026A4 (en) INHIBITORS OF HCV NS3 PROTEASE
EP2470189A4 (en) METHODS FOR PREPARING HEPATITIS C VIRUS PROTEASE INHIBITORS
EP2740734A4 (en) HCV Protease Inhibitors
EP2576564A4 (en) MACROCYCLIC HEPATITIS C SERIN PROTEASE INHIBITORS
HK1164839A1 (zh) 用於製備 的大環蛋白酶抑制劑的方法及中間體
EP2658859A4 (en) MACROCYCLIC HEPATITIS C SERIN PROTEASE INHIBITORS
HK1200847A1 (en) Inhibitors of hcv ns5a hcv ns5a
EP2771332A4 (en) HIV PROTEASE INHIBITORS
IL221242A0 (en) Processes and intermediates for preparing a macrocyclic protease inhibitor of hcv
EP2725264A4 (en) PRESSURE SEGMENT AND METHOD FOR MANUFACTURING THE SAME
AP2013006733A0 (en) Solid state forms of a potent HCV inhibitor
GB201222956D0 (en) Removal of components from a starting material
HK1199449A1 (en) Processes and intermediates for preparing a macrocyclic protease inhibitor of hcv hcv
GB201110835D0 (en) A furnace and method of operating a furnace
IL233550A0 (en) Stable pharmaceutical formulations of an effective hepatitis c virus inhibitor
IL229426A0 (en) processes and intermediates
HK1247246A1 (zh) 用於製備hcv的大環蛋白酶抑制劑的方法和中間體
HK1201277A1 (zh) 用於製備 蛋白酶抑制劑的方法
HK1197229A1 (en) Process for the preparation of protease inhibitors
SG2014012538A (en) Method of protecting patterned magnetic materials
GB201402214D0 (en) Lock and method of operation of a lock

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20210920